特雷维治疗 TRVI
$14.33 +$1.52 (+11.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.90 +3.98%
开盘$13.04
昨收$12.81
当日区间$13.00 – $14.36
成交量2.55M
市值$2.04B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$20.51M-49.5% YoY
净利润-$17.80M-44.7% YoY
摊薄每股收益-$0.11-22.2% YoY
自由现金流-$17.55M-73.8% YoY
经营现金流-$17.43M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-19.7%
资产收益率-19.0%
投入资本回报率-22.8%
流动比率37.28
负债/资产比率2.7%
现金及投资$318.87M
总负债$276,000.00
净现金（净负债）$318.59M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $20.51M | $14.91M | $49.33M | $10.22M | $13.92M |
| 销售及管理费用 | $5.36M | $4.97M | $15.85M | $4.03M | $3.83M |
| -管理费用 | $5.36M | $4.97M | $15.85M | $4.03M | $3.83M |
| 研发费用 | $15.15M | $9.94M | $33.48M | $6.19M | $10.09M |
| 营业利润 | -$20.51M | -$14.91M | -$49.33M | -$10.22M | -$13.92M |
| 非经营性利息净收入（支出） | $2.70M | $1.70M | $6.54M | $1.90M | $2.10M |
| 非经营性利息收入 | $2.70M | $1.70M | $6.54M | $1.90M | $2.10M |
| 其他收入（支出） | -$3,000.00 | $4,000.00 | -$31,000.00 | -$15,000.00 | -$2,000.00 |
| 其他非经营性收入（支出） | -$3,000.00 | $4,000.00 | -$31,000.00 | -$15,000.00 | -$2,000.00 |
| 税前利润 | -$17.82M | -$13.21M | -$42.82M | -$8.33M | -$11.82M |
| 税费 | -$19,000.00 | -$20,000.00 | -$64,000.00 | -$16,000.00 | -$15,000.00 |
| 净利润 | -$17.80M | -$13.19M | -$42.76M | -$8.32M | -$11.80M |
| 持续经营利润 | -$17.80M | -$13.19M | -$42.76M | -$8.32M | -$11.80M |
| 归属母公司净利润 | -$17.80M | -$13.19M | -$42.76M | -$8.32M | -$11.80M |
| 归属普通股股东净利润 | -$17.80M | -$13.19M | -$42.76M | -$8.32M | -$11.80M |
| 基本每股收益 | -$0.11 | -$0.09 | -$0.32 | -$0.06 | -$0.08 |
| 摊薄每股收益 | -$0.11 | -$0.09 | -$0.32 | -$0.06 | -$0.08 |
| 非经营性利息支出 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $330.52M | $179.61M | $193.44M | $193.44M | $199.36M |
| 流动资产合计 | $325.71M | $176.12M | $191.66M | $191.66M | $198.30M |
| 现金及现金等价物与短期投资 | $318.87M | $171.78M | $188.26M | $188.26M | $194.93M |
| -现金及现金等价物 | $54.30M | $19.41M | $18.91M | $18.91M | $56.87M |
| -短期投资 | $264.57M | $152.37M | $169.35M | $169.35M | $138.06M |
| 预付资产 | $4.26M | $2.22M | $1.26M | $1.26M | $1.38M |
| 其他流动资产 | $2.57M | $2.12M | $2.13M | $2.13M | $2.00M |
| 非流动资产合计 | $4.81M | $3.49M | $1.78M | $1.78M | $1.06M |
| 固定资产净值 | $878,000.00 | $875,000.00 | $855,000.00 | $855,000.00 | $954,000.00 |
| -固定资产原值 | $878,000.00 | $875,000.00 | $1.21M | $1.21M | $954,000.00 |
| 其他非流动资产 | $3.94M | $2.61M | $928,000.00 | $928,000.00 | $103,000.00 |
| 负债合计 | $9.01M | $7.48M | $10.20M | $10.20M | $9.57M |
| 流动负债合计 | $8.74M | $7.12M | $9.75M | $9.75M | $9.04M |
| 应付款 | $3.10M | $2.22M | $3.91M | $3.91M | $2.71M |
| -应付账款 | $3.10M | $2.22M | $3.91M | $3.91M | $2.71M |
| 一年内应计费用 | $3.21M | $3.31M | $2.79M | $2.79M | $3.65M |
| 短期债务及融资租赁负债 | $329,000.00 | $318,000.00 | $307,000.00 | $307,000.00 | $296,000.00 |
| -一年内到期融资租赁负债 | $329,000.00 | $318,000.00 | $307,000.00 | $307,000.00 | $296,000.00 |
| 非流动负债合计 | $276,000.00 | $364,000.00 | $446,000.00 | $446,000.00 | $527,000.00 |
| 长期债务及融资租赁负债 | $276,000.00 | $364,000.00 | $446,000.00 | $446,000.00 | $527,000.00 |
| -长期融资租赁负债 | $276,000.00 | $364,000.00 | $446,000.00 | $446,000.00 | $527,000.00 |
| 股东权益合计 | $321.51M | $172.13M | $183.24M | $183.24M | $189.79M |
| 股东权益 | $321.51M | $172.13M | $183.24M | $183.24M | $189.79M |
| 股本 | $142,000.00 | $128,000.00 | $128,000.00 | $128,000.00 | $128,000.00 |
| -普通股 | $142,000.00 | $128,000.00 | $128,000.00 | $128,000.00 | $128,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $682.58M | $515.19M | $512.77M | $512.77M | $511.12M |
| 留存收益 | -$360.79M | -$343.00M | -$329.80M | -$329.80M | -$321.49M |
| 不影响留存收益的损益 | -$425,000.00 | -$190,000.00 | $148,000.00 | $148,000.00 | $30,000.00 |
| -累计折旧 | – | – | -$359,000.00 | -$359,000.00 | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$17.43M | -$16.69M | -$42.09M | -$7.63M | -$10.88M |
| 持续经营经营活动现金流净额 | -$17.43M | -$16.69M | -$42.09M | -$7.63M | -$10.88M |
| 持续经营净利润 | -$17.80M | -$13.19M | -$42.76M | -$8.32M | -$11.80M |
| 折旧、折耗与摊销 | $34,000.00 | $34,000.00 | $144,000.00 | $31,000.00 | $38,000.00 |
| 其他非现金项目 | $102,000.00 | $105,000.00 | $463,000.00 | $133,000.00 | $108,000.00 |
| 营运资金变动 | -$2.52M | -$5.40M | -$3.49M | -$274,000.00 | -$169,000.00 |
| -预付资产变动 | -$2.93M | -$2.84M | -$1.48M | $158,000.00 | -$30,000.00 |
| -应付账款及应计费用变动 | $409,000.00 | -$2.56M | -$2.01M | -$432,000.00 | -$139,000.00 |
| 投资活动现金流净额 | -$112.04M | $16.97M | -$94.11M | -$30.61M | -$50.94M |
| 持续经营投资活动现金流净额 | -$112.04M | $16.97M | -$94.11M | -$30.61M | -$50.94M |
| 固定资产购置及出售净额 | -$124,000.00 | -$102,000.00 | -$12,000.00 | $0.00 | -$12,000.00 |
| 投资购置及出售净额 | -$111.91M | $17.07M | -$94.10M | -$30.61M | -$50.93M |
| 筹资活动现金流 | $164.36M | $222,000.00 | $121.01M | $284,000.00 | $1.63M |
| 持续经营筹资活动现金流净额 | $164.36M | $222,000.00 | $121.01M | $284,000.00 | $1.63M |
| 债务发行及偿还净额 | $0.00 | $0.00 | -$11,000.00 | $0.00 | $0.00 |
| 股票期权行使所得 | $1.79M | $222,000.00 | $12.95M | $284,000.00 | $1.12M |
| 期末现金余额 | $54.30M | $19.41M | $18.91M | $18.91M | $56.87M |
| 现金净变动 | $34.89M | $498,000.00 | -$15.18M | -$37.96M | -$60.19M |
| 期初现金余额 | $19.41M | $18.91M | $34.10M | $56.87M | $117.06M |
| 自由现金流 | -$17.55M | -$16.79M | -$42.10M | -$7.63M | -$10.89M |
| 持续经营损益 | – | – | $7,000.00 | – | – |
| 普通股发行净额 | – | – | $108.15M | $0.00 | $0.00 |
| 其他筹资费用净额 | – | – | -$84,000.00 | $0.00 | $506,000.00 |
暂无评论——快来第一个聊聊 TRVI。
登录后参与讨论。